RPL23A and ovarian cancer: A seven-hub-molecule-signature model (HIBCH, HIST1H2BK, ALB, EIF3E, RPS20, RRAS2, and RPL23A) from a multivariate regression analysis can predict the survival risks of ovarian cancer [17].